Back to Top Skip to main content Skip to sub-navigation

Department of Defense Mid-Season Vaccine Effectiveness Estimates for the 2019– 2020 Influenza Season

Image of 201019-N-PC065-1062 NORFOLK (Oct. 19, 2020) Hospital Corpsman 2nd Class Sashee Robinson, assigned to amphibious transport dock ship USS Arlington (LPD 24), administers an influenza vaccine to Machinery Repairman 2nd Class Hannah Swearingen in medical aboard the Arlington. Influenza vaccines are an annual medical readiness requirement throughout the Department of Defense. (U.S. Navy photo by Mass Communication Specialist 2nd Class John Bellino/Released). Hospital Corpsman 2nd Class Sashee Robinson, assigned to amphibious transport dock ship USS Arlington (LPD 24), administers an influenza vaccine to Machinery Repairman 2nd Class Hannah Swearingen in medical aboard the Arlington. Influenza vaccines are an annual medical readiness requirement throughout the Department of Defense. (U.S. Navy photo by Mass Communication Specialist 2nd Class John Bellino)

Recommended Content:

Medical Surveillance Monthly Report

What are the New Findings?

The 2019-2020 influenza vaccine provided moderate protection against influenza for beneficiary and civilian populations within the Department of Defense (DOD) and low to moderate protection against influenza for active component service members.

What is the Impact on Readiness and Force Health Protection?

Components of the influenza vaccine can change each season and novel influenza strains can appear and circulate among active component and DOD beneficiary populations. Conducting Vaccine Effectiveness (VE) studies every year can assist vaccine policy makers in making their decisions on strain selection for the influenza vaccine for the subsequent season, thus creating the most effective influenza vaccine, which can reduce morbidity and improve military readiness.

Abstract

This report provides mid-season VE estimates from the Armed Forces Health Surveillance Division (AFHSD), the DOD Global Respiratory Pathogen Surveillance (DODGRS) program, and the Naval Health Research Center (NHRC) for the 2019-2020 influenza season. Using a test negative case-control study design, the AFHSD performed a VE analysis for active component service members while the DODGRS program and NHRC collaborated to perform a VE analysis for DOD beneficiaries and U.S.-Mexico border civilians. Among active component service members, there was low to moderate protection against influenza B, moderate protection against A(H3N2), and non-statistically significant low protection against influenza A overall and A(H1N1). Among DOD beneficiaries and U.S.-Mexico border civilians, there was statistically significant moderate protection against influenza B, influenza A overall, A(H1N1), and A(H3N2).

Background

Historically, military populations have been stationed in congregate settings that predispose them to acute respiratory infections, resulting in significantly increased morbidity, which has impacted military readiness.1 In previous seasons, it was estimated that 300,000 to 400,000 active component service members had medical encounters for respiratory infections.2 Specifically, influenza has had a significant impact on the military population for over a century. During the influenza pandemic of 1918, 43,000 U.S. service members were killed due to the H1N1 pandemic strain that was circulating at the time, constituting approximately 40% of all U.S. war deaths during World War I.3 On a yearly basis, the U.S. military requires influenza vaccination among active component personnel, with a goal of exceeding 90% immunization by mid-December of each year.2

Despite the high vaccination rate among the military population, vaccine breakthrough cases still occur. From 2007 through 2012, the Armed Forces Health Surveillance Division (AFHSD) reported 7,000–25,000 cases of influenza infections to the Military Health System each week of the influenza seasons, 3,000 to 16,000 of which were military personnel.2,4,5 The Department of Defense conducts year-round influenza surveillance for military health beneficiaries and civilian populations, and the DOD uses these data to estimate midseason influenza VE, which is submitted annually to the Food and Drug Administration Vaccine and Related Biological Advisory Committee meeting. This report presents the mid-season VE estimates from the DOD 2019–2020 influenza season surveillance.

Methods

Two separate analyses were performed to produce mid-season DOD VE estimates, both using a test-negative, case-control study design. The study population for the AFHSD analysis consisted of active component service members from the Army, Air Force, Navy, and Marine Corps stationed in the U.S. and abroad who were tested for influenza. Subjects were identified using the Defense Medical Surveillance System Health Level 7 data from the Navy and Marine Corps Public Health Center, and service member data from the Naval Health Research Center (NHRC) for specimens collected for influenza testing from 1 November 2019 to 15 February 2020. The AFHSD identified cases by either a positive reverse transcription polymerase chain reaction (RT-PCR), viral culture, or rapid test. Cases were laboratory-confirmed influenza positives and controls were influenza test negatives. Active component service members with a negative rapid test were excluded. Influenza vaccination status was ascertained through documentation in medical records. Subjects were considered vaccinated if the laboratory specimens were collected 14 days or more after vaccination. Crude and adjusted VE estimates were calculated using odds ratios (ORs) and 95% confidence intervals (CIs) obtained from multivariable logistic regression models. VE estimates were adjusted for sex, age category, and month of specimen collection. VE was calculated as (1−OR) × 100. Results were stratified by influenza subtype. Due to differences in the timing of circulating influenza strains this season, the influenza B and influenza A(H3N2) analyses used specimens from the entire period of 1 November 2019 to 15 February 2020, whereas the influenza A overall and influenza A(H1N1) analyses were restricted to the peak influenza A circulation period of 1 January 2020 to 15 February 2020. Influenza A(H3N2) cases were few and sporadic throughout the season, which is why the entire period was used. All vaccinated populations were restricted to subjects who received inactivated influenza vaccine because the live attenuated influenza vaccine was not routinely used among active component service members during the 2019–2020 season.

The DOD Global Respiratory Pathogen Surveillance (DODGRS) program and NHRC combined their surveillance data to estimate VE among DOD beneficiaries and civilians whose specimens were collected from 3 November 2019 to 15 February 2020. Active component members were excluded from this analysis. Data from the DODGRS program pertained to DOD dependents who visited military treatment facilities and whose specimens were sent to and tested at the U.S. Air Force School of Aerospace Medicine (USAFSAM). NHRC's data pertained to civilian populations who visited clinics near the U.S.-Mexico border and outpatient DOD beneficiaries in Southern California and Illinois. Cases were patients whose laboratory tests confirmed the presence of influenza virus, and controls were patients whose influenza tests were negative. Cases and controls were identified by RT-PCR and/or viral culture. Vaccination status was determined through electronic immunization records from the Air Force Complete Immunization Tracking Application or self-report from questionnaires. Individuals were considered vaccinated if they received the vaccine at least 14 days prior to their specimen collection date. Those whose vaccination status could not be ascertained or those who were vaccinated within 14 days prior to their illness were excluded. Crude and adjusted VE estimates for this analysis were also calculated using ORs and 95% CIs obtained from multivariable logistic regression models. VE estimates were adjusted for age group, time of specimen collection, location, and sex. VE was calculated as (1−OR) × 100. Results were stratified by influenza subtype and population (all dependents, aged 2-17 years, and aged 18 years or older) (Table 1). Because of insufficient data, a sub-analysis for the elderly population (aged 65 years or older) was not possible.

Results

For AFHSD's active component service member influenza B and A(H3N2) analysis (November to February), there were 2,033 and 37 laboratory-confirmed cases of influenza B and A(H3N2), respectively, and 4,982 test-negative controls. For AFHSD's active component service member influenza A (any subtype) and A(H1N1) analysis (January to February), there were 1,911 and 347 laboratory-confirmed cases of influenza A (any subtype) and A(H1N1), respectively, and 2,222 test-negative controls. Although the crude VE estimate for influenza B was not statistically significantly different from zero, the adjusted VE estimate was statistically significant at 31%. The crude and adjusted VE estimates for influenza A(H3N2) were statistically significant at 49% and 58%, respectively. The adjusted VE estimates for influenza A (any subtype) and A(H1N1) did not reach statistical significance at 12% and 28%, respectively. The confidence intervals for crude and adjusted VE estimates are shown in the Table.

For the USAFSAM/NHRC DOD beneficiary and civilian analysis, there were 1,595 confirmed cases and 2,150 controls. With the exception of influenza A(H3N2) in adults, all adjusted VE estimates were statistically significantly different from zero. Moreover, the VE estimates were substantially higher for influenza B (unadjusted and adjusted) and influenza A(H3N2) (adjusted) than for influenza A(H1N1) and all influenza A subtypes.

Editorial Comment

Among active component service members, the mid-season 2019–2020 estimates of influenza vaccine effectiveness indicated moderate protection against A(H3N2) (58%), low to moderate protection against influenza B (31%), and non-statistically significant low protection against influenza A overall (12%) and A(H1N1) (28%). Estimates for the DoD beneficiaries and civilian population indicate a statistically significant moderate protection against overall influenza diagnosis (54%), influenza B (51%), influenza A (any subtype) (45%), A(H1N1) (42%), and A(H3N2) (60%). Mid-season VE estimates for active component service members were higher and statistically significant compared with the previous season.7 This could potentially be due to the 2019–2020 season being more severe and having a higher volume of testing, which resulted in a larger sample size and improved statistical power of the analyses. VE estimates for the DoD beneficiaries and civilian populations were similar to interim estimates from the Centers for Disease Control and Prevention's VE analysis for the 2019–2020 influenza season.8

There were limitations to these analyses. Results for the active component service member analysis are for medically attended illnesses that were tested for influenza; therefore, the result may not be applicable to less severe illnesses that did not result in a medical encounter for the 2019– 2020 influenza season. Among the active component service member population, influenza vaccination is mandatory, so this population is highly immunized. This could have a negative impact on VE, with potential statistical issues and biological effects such as attenuated immune response with repeated exposures. The DOD beneficiaries and civilians analysis was unable to calculate VE estimates for the elderly population due to insufficient data. Additionally, self-reported data from the questionnaire could result in potential recall bias on the analysis. However, this bias was curtailed for self-reported vaccination status by excluding those whose status could not be ascertained and electronic immunization records were used instead, if available.

Because of the rapidly changing nature of the influenza virus, it is imperative for researchers to continue to assess the effectiveness of the influenza vaccine, as well as to enhance methods of VE analyses for more accurate estimates, and to take waning immunity and repeated vaccinations into account. Future research on these concepts could bring forth benefits and have an influence on decision-making for vaccination policies, especially for the military.

Author affiliations: STS Systems Integration, LLC, San Antonio, TX (Mr. Thervil, Ms. DeMarcus); Wright-Patterson Air Force Base-Air Force satellite, U.S. Air Force School of Aerospace Medicine, Ohio (Mr. Thervil, Ms. DeMarcus); Cherokee Nation Strategic Solutions, Tulsa, OK (Dr. Cost, Ms. Hu); Defense Health Agency, Armed Forces Health Surveillance Division, Silver Spring, MD (Dr. Cost, Ms. Hu); Naval Health Research Center, San Diego, CA (Dr. Myers, Dr. Hollis, Ms. Balansay-Ames, Ms. Ellis, Dr. Christy); General Dynamics Information Technology, San Diego, CA (Ms. Balansay-Ames, Ms. Ellis).

Disclaimer: The authors are military service members or employees of the U.S. Government. This work was prepared as part of their official duties. Title 17, U.S.C. §105 provides that copyright protection under this title is not available for any work of the U.S. Government. Title 17, U.S.C. §101 defines a U.S. Government work as work prepared by a military service member or employee of the U.S. Government as part of that person's official duties. Report No. 21-21 was supported by Global Emerging Infections Surveillance & Response System Operations (GEIS) under work unit nos. 60501 and GEIS Promis ID P0151_20_US_01. The views expressed in this article are those of the authors and do not necessarily reflect the official policy or position of the Department of the Navy, Department of Defense, nor the U.S. Government.

References

1. Ho ZJM, Hwang YFJ, Lee JMV. Emerging and re-emerging infectious diseases: challenges and opportunities for militaries. Mil Med Res. 2014;1:21.

2. Sanchez JL, Cooper MJ, Myers CA, et al. Respiratory infections in the U.S. military: recent experience and control. Clin Microbiol Rev. 2015;28(3):743-800.

3. Clarke T Jr. Pandemic, 1918. Mil Med. 2016; 81(8):941-942.

4. Sanchez JL, Cooper MJ. Influenza in the US military: an overview. J Infect Dis Treat. 2016;2:1.

5. Update: pneumonia-influenza and severe acute respiratory illnesses, active component, U.S. Armed Forces, July 2000-June 2012. MSMR. 2012;19:11-13.

6. Toure E, Eick-Cost AA, Hawksworth AW, et al. Brief report: mid-season influenza vaccine effectiveness estimates for the 2016-2017 influenza season. MSMR. 2017;24(8):17-19.

7. Lynch LC, Coleman R, DeMarcus L, et al. Brief report: Department of Defense midseason estimates of vaccine effectiveness for the 2018-2019 influenza season. MSMR. 2019;26(7):24–27. 

8. Dawood FS, Chung JR, Kim SS, et al. Interim estimates of 2019–20 seasonal influenza vaccine effectiveness—United States, February 2020. MMWR Morb Mortal Wkly Rep. 2020;69:177-182.

TABLE. Mid-season crude and adjusted influenza VE estimates, by influenza subtype and population, 2019–2020 influenza season

You also may be interested in...

Exertional Hyponatremia, Active Component, U.S. Armed Forces, 2006–2021

Article
4/1/2022
Marine Corps Cpl. Luis Alicea drinks water after a combat conditioning exercise at Naval Air Station Joint Reserve Base New Orleans, May 20, 2019. Photo By: Marine Corps Lance Cpl. Jose Gonzalez.

Exertional (or exercise-associated) hyponatremia refers to a low serum, plasma, or blood sodium concentration (below 135 mEq/L) that develops during or up to 24 hours following prolonged physical activity. Acute hyponatremia creates an osmotic imbalance between fluids outside and inside of cells.

Recommended Content:

Medical Surveillance Monthly Report

Exertional Rhabdomyolysis, Active Component, U.S. Armed Forces, 2017–2021

Article
4/1/2022

Exertional rhabdomyolysis is a potentially serious condition that requires a vigilant and aggressive approach. Some service members who experience exertional rhabdomyolysis may be at risk for recurrences, which may limit their military effectiveness and potentially predispose them to serious injury.

Recommended Content:

Medical Surveillance Monthly Report

Exertional Heat Illness at Fort Benning, GA: Unique Insights from the Army Heat Center

Article
4/1/2022
Navy Petty Officer 3rd Class Ryan Adams is being used as an example victim for cooling a heat casualty at the bi-annual hot weather standard operating procedure training aboard Marine Corps Base Camp Lejeune, N.C., Aug. 24. Adams is demonstrating the "burrito" method used to cool a heat related injury victim. Photo by Pfc. Joshua Grant.

Exertional heat illness (hereafter referred to as heat illness) spans a spectrum from relatively mild conditions such as heat cramps and heat exhaustion, to more serious and potentially life-threatening conditions such as heat injury and exertional heat stroke (hereafter heat stroke).

Recommended Content:

Medical Surveillance Monthly Report

Heat Illness, Active Component, U.S. Armed Forces, 2021

Article
4/1/2022

From 2020 to 2021, the rate of incident heat stroke was relatively stable while the rate of heat exhaustion increased slightly

Recommended Content:

Medical Surveillance Monthly Report

Obesity prevalence among active component service members prior to and during the COVID-19 pandemic, January 2018–July 2021

Article
3/1/2022
Maintaining a healthy weight is important for military members to stay fit to fight. The body mass index is a tool that can be used to determine if an individual is at an appropriate weight for their height. A person’s index is determined by their weight in kilograms divided by the square of height in meters. (U.S. Air Force photo illustration by Airman 1st Class Destinee Sweeney)

This study examined monthly prevalence of obesity and exercise in active component U.S. military members prior to and during the COVID-19 pandemic. These results suggest that the COVID-19 pandemic had a small effect on the trend of obesity in the active component U.S. military and that obesity prevalence continues to increase.

Recommended Content:

Medical Surveillance Monthly Report

Brief report: Using syndromic surveillance to monitor MIS-C associated with COVID-19 in Military Health System beneficiaries

Article
3/1/2022
Air Force 1st Lt. Anthony Albina, a critical care nurse assigned to Joint Base Andrews, Md., checks a patient’s breathing and heart rate during an intubation procedure while supporting COVID-19 response operations in Cleveland, Jan. 20, 2022.

SARS CoV-2 and the illness it causes, COVID-19, have exacted a heavy toll on the global community. Most of the identified disease has been in the elderly and adults. The goal of this analysis was to ascertain if user-built ESSENCE queries applied to records of outpatient MHS health care encounters are capable of detecting MIS-C cases that have not been identified or reported by local public health departments.

Recommended Content:

Medical Surveillance Monthly Report

Surveillance Snapshot: Medical Separation from Service Among Incident Cases of Osteoarthritis and Spondylosis, Active Component, U.S. Armed Forces, 2016–2020

Article
3/1/2022
Marines hike to the next training location during Exercise Baccarat in Aveyron, Occitanie, France, Oct.16, 2021. Exercise Baccarat is a three-week joint exercise with Marines and the French Foreign Legion that challenges forces with physical and tactical training. Photo By: Marine Corps Lance Cpl. Jennifer Reyes

Osteoarthritis (OA) is the most common adult joint disease and predominantly involves the weight-bearing joints. This condition, including spondylosis (OA of the spine), results in significant disability and resource utilization and is a leading cause of medical separation from military service.

Recommended Content:

Medical Surveillance Monthly Report

Update: Malaria, U.S. Armed Forces, 2021

Article
3/1/2022
Mosquitos – like this one, collected as part of a military study in North Carolina – were used during USAMRDC’s initial RTS,S vaccine studies nearly 40 years ago. (Photo courtesy: AFC Kimberly Barrera)

Malaria infection remains an important health threat to U.S. service members who are located in endemic areas because of long-term duty assignments, participation in shorter-term contingency operations, or personal travel. In 2021, a total of 20 service members were diagnosed with or reported to have malaria.

Recommended Content:

Medical Surveillance Monthly Report

Brief Report: Refractive Surgery Trends at Tri-Service Refractive Surgery Centers and the Impact of the COVID-19 Pandemic, Fiscal Years 2000–2020

Article
3/1/2022
Cadet Saverio Macrina, U.S. Military Academy West Point, receives corneal cross-linking procedure at Fort Belvoir Community Hospital, Va., Nov. 21, 2016. (DoD photo by Reese Brown)

Since the official introduction of laser refractive surgery into clinical practice throughout the Military Health System (MHS) in fiscal year 2000, these techniques have been heavily implemented in the tri-service community to better equip and improve the readiness of the U.S. military force.

Recommended Content:

Medical Surveillance Monthly Report

Surveillance snapshot: Health care burden attributable to osteoarthritis and spondylosis, active component, U.S. Armed Forces, 2016–2020

Article
2/1/2022
Air Force security forces trainees climb a hill during a 3-mile ruck march to commemorate National Police Week at Joint Base San Antonio, May 13, 2019. Photo By: Sarayuth Pinthong, Air Force

This snapshot summarizes the total numbers of inpatient and outpatient encounters with an OA or spondylosis diagnosis in the first diagnostic position and the total numbers of unique individuals affected by these conditions during the same 5-year surveillance period.

Recommended Content:

Medical Surveillance Monthly Report

A new approach to categorization of ocular injury among U.S. Armed Forces

Article
2/1/2022
Air Force and Space Force Surgeon General Lt. Gen. Dorothy Hogg receives an eye exam from Air Force Reserve Maj. Leslie Wilderson at Joint Base Anacostia-Bolling, Washington, D.C., March 26, 2021. Photo By: Air Force Staff Sgt. Kayla White

Ocular injuries present an ongoing threat to readiness and retention of service members. This report describes a new approach to categorizing ocular injury using Military Health System data, the application of an algorithm to a dataset, and the verification of the results using an audit of clinical data.

Recommended Content:

Medical Surveillance Monthly Report

Diagnosis of hepatitis C infection and cascade of care in the active component, U.S. Armed Forces, 2020

Article
2/1/2022
Navy Petty Officer 2nd Class Cecil Dorse, left, and Navy Petty Officer 3rd Class Janet Rosas test blood samples aboard the Military Sealift Command hospital ship USNS Comfort while the ship is in New York City in support of the nation’s COVID-19 response, April 6, 2020. Photo By: Navy Petty Officer 2nd Class Sara Eshleman

Hepatitis C virus (HCV) infection rates are rising in the U.S. despite widely available tools to identify and effectively treat nearly all of these cases. This cross-sectional study aimed to use laboratory data to evaluate the prevalence of HCV diagnoses among active component U.S. military service members.

Recommended Content:

Medical Surveillance Monthly Report

Surveillance Snapshot: Lengths of Hospital Stays for Service Members Diagnosed with Sepsis, Active Component, U.S. Armed Forces, 2011–2020

Article
1/1/2022
The (left to right) Senior Airman Austin Shrewsbury, 88th Diagnostics and Therapeutic Squadron medical laboratory technician, works with student, Airman 1st Class Taylor Altman, 88th Diagnostics and Therapeutic Squadron medical laboratory technician, to identify bacteria of patient’s cultures inside the microbiology laboratory at Wright-Patterson Air Force Base medical center June 30, 2017.

Sepsis is a serious and life-threatening organ dysfunction caused by a dysregulated host response to infection. In the U.S., sepsis is a leading cause of in-hospital mortality and 1 of the most expensive conditions treated in U.S. hospitals.

Recommended Content:

Medical Surveillance Monthly Report

Description of a COVID-19 Beta Variant Outbreak, Joint Base Lewis-McChord, WA, February–March 2021

Article
1/1/2022
U.S. Army Soldiers from 1-17th Infantry Battalion, 2nd Stryker Brigade, 2nd Infantry Division, clear an objective during the training exercise Bayonet Focus 19-02 at Yakima Training Center, Wash., May 6, 2019. Bayonet Focus is a training exercise designed to assess Soldiers’ ability to preform tasks and complete objectives under conditions experienced during combat situations. (U.S. Army photo by Spc. Angel Ruszkiewicz)

This report describes an outbreak of SARS-CoV-2, the causative agent of COVID-19, that peaked during 21–26 February 2021 and was tied to a single military training event. A total of 143 laboratory-confirmed cases were identified.

Recommended Content:

Medical Surveillance Monthly Report

COVID-19 and Depressive Symptoms Among Active Component U.S. Service Members, January 2019–July 2021

Article
1/1/2022
With the holiday season upon us, the cold, dark days that winter brings, and the social distancing and movement restrictions brought about by COVID-19, it’s not uncommon for people to feel depressed. (Photo by Erin Bolling)

This study examined the rates of depressive symptoms in active component U.S. service members prior to and during the COVID-19 pandemic and evaluated whether SARS-CoV-2 test results (positive or negative) were associated with self-reported depressive symptoms.

Recommended Content:

Medical Surveillance Monthly Report
<< < 1 2 3 4 5  ... > >> 
Showing results 1 - 15 Page 1 of 16
Refine your search
Last Updated: August 27, 2021

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.